Case Report: Biological treatment of epidermolysis bullosa acquisita: report on four cases and literature review

Epidermolysis bullosa acquisita (EBA) is a chronic, recurrent autoimmune subepidermal bullous disease characterized by the presence of autoantibodies targeting type VII collagen -- basement membrane zone antigen. Standard therapy for EBA includes a combination of systemic corticosteroids and dapsone...

Descripción completa

Detalles Bibliográficos
Autores principales: Szymański, Konrad, Kowalewski, Cezary, Pietrzyk, Ewelina, Woźniak, Katarzyna
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2023
Materias:
Immunology
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10371012/
https://www.ncbi.nlm.nih.gov/pubmed/37503352
http://dx.doi.org/10.3389/fimmu.2023.1214011

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10371012/
https://www.ncbi.nlm.nih.gov/pubmed/37503352
http://dx.doi.org/10.3389/fimmu.2023.1214011

Ejemplares similares